EFFECT OF LOCAL-DELIVERY OF HEPARIN AND METHOTREXATE ON NEOINTIMAL PROLIFERATION IN STENTED PORCINE CORONARY-ARTERIES

被引:30
作者
COX, DA
ANDERSON, PG
ROUBIN, GS
CHOU, CY
AGRAWAL, SK
CAVENDER, JB
机构
[1] UNIV ALABAMA,DIV CARDIOVASC DIS,BIRMINGHAM,AL 35294
[2] UNIV ALABAMA,DEPT PATHOL,BIRMINGHAM,AL 35294
关键词
RESTENOSIS; ANGIOPLASTY; BALLOON; CORONARY DISEASE;
D O I
10.1097/00019501-199203000-00011
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Multiple systemic agents have not prevented restenosis after percutaneous transluminal coronary angioplasty. Attention has focused more recently on developing local drug delivery systems that achieve significant focal concentrations of agents potentially effective against restenosis. Recent advances in polymer design allow specific drugs to be eluted within a defined period after polymer binding onto intracoronary stents. Preliminary results suggested heparin and methotrexate may inhibit the neointimal smooth muscle cell proliferation involved in restenosis. We investigated whether a local drug delivery system involving polymer binding of methotrexate, heparin, or both agents onto an intracoronary stent would inhibit neointimal smooth muscle cell proliferation in a model involving oversized stenting of porcine coronary arteries. Methods: Forty animals were randomly divided into four treatment groups. Ten pigs each received a flexible, balloon-expandable tantalum stent coated with a cellulose ester polymer that bound methotrexate, heparin, or a combination of both drugs; 10 animals received an uncoated tantalum control stent. All animals were fed a nonatherogenic diet and were killed 28 days after stenting. Morphometric analysis of stented arteries was performed; mean neointimal area and percent lumen area stenosis were compared between treatment groups. Results: No statistically significant differences were found between treatment groups by 2 x 2 factorial analysis with respect to either mean neointimal area or percent lumen area stenosis. Conclusions: This preliminary attempt to inhibit neointimal smooth muscle cell proliferation after vascular injury by local delivery of methotrexate and heparin with polymer-coated intracoronary stents was unsuccessful. Further efforts to refine polymer-based local drug delivery systems may involve more effective antiproliferative agents and more extensive surface areas for drug delivery.
引用
收藏
页码:237 / 248
页数:12
相关论文
共 51 条
[1]   VASCULAR REMODELING AND IMPROVEMENT OF CORONARY RESERVE AFTER HYDRALAZINE TREATMENT IN SPONTANEOUSLY HYPERTENSIVE RATS [J].
ANDERSON, PG ;
BISHOP, SP ;
DIGERNESS, SB .
CIRCULATION RESEARCH, 1989, 64 (06) :1127-1136
[2]   INTIMAL PROLIFERATION OF SMOOTH-MUSCLE CELLS AS AN EXPLANATION FOR RECURRENT CORONARY-ARTERY STENOSIS AFTER PERCUTANEOUS TRANS-LUMINAL CORONARY ANGIOPLASTY [J].
AUSTIN, GE ;
RATLIFF, NB ;
HOLLMAN, J ;
TABEI, S ;
PHILLIPS, DF .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1985, 6 (02) :369-375
[3]  
BARATH P, 1989, Journal of the American College of Cardiology, V13, p252A
[4]   INVIVO AND INVITRO RELEASE OF MACROMOLECULES FROM POLYMERIC DRUG DELIVERY SYSTEMS [J].
BROWN, LR ;
WEI, CL ;
LANGER, R .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1983, 72 (10) :1181-1185
[5]  
CARRINGTON CB, 1968, INT ACADEMY PATHOLOG, V8, P317
[6]   REGULATION OF VASCULAR SMOOTH-MUSCLE CELL-GROWTH BY HEPARIN AND HEPARAN SULFATES [J].
CASTELLOT, JJ ;
WRIGHT, TC ;
KARNOVSKY, MJ .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1987, 13 (04) :489-503
[7]   CULTURED ENDOTHELIAL-CELLS PRODUCE A HEPARIN-LIKE INHIBITOR OF SMOOTH-MUSCLE CELL-GROWTH [J].
CASTELLOT, JJ ;
ADDONIZIO, ML ;
ROSENBERG, R ;
KARNOVSKY, MJ .
JOURNAL OF CELL BIOLOGY, 1981, 90 (02) :372-379
[8]  
CASTELLOT JJ, 1987, VASCULAR SMOOTH MUSC, P93
[9]  
CAVENDER JB, 1990, CIRCULATION, V82, P541
[10]   SUPPRESSION BY HEPARIN OF SMOOTH-MUSCLE CELL-PROLIFERATION IN INJURED ARTERIES [J].
CLOWES, AW ;
KARNOWSKY, MJ .
NATURE, 1977, 265 (5595) :625-626